当前位置: 首页 >> 检索结果
6969. Assessment of protection against reinfection with SARS-CoV-2 among 4 million PCR-tested individuals in Denmark in 2020: a population-level observational study.
作者: Christian Holm Hansen.;Daniela Michlmayr.;Sophie Madeleine Gubbels.;Kåre Mølbak.;Steen Ethelberg.
来源: Lancet. 2021年397卷10280期1204-1212页
The degree to which infection with SARS-CoV-2 confers protection towards subsequent reinfection is not well described. In 2020, as part of Denmark's extensive, free-of-charge PCR-testing strategy, approximately 4 million individuals (69% of the population) underwent 10·6 million tests. Using these national PCR-test data from 2020, we estimated protection towards repeat infection with SARS-CoV-2.
6975. 10 years of the Syrian conflict: a time to act and not merely to remember.
作者: Samer Jabbour.;Jennifer Leaning.;Iman Nuwayhid.;Alastair Ager.;Melani Cammett.;Omar Dewachi.;Fouad M Fouad.;Rita Giacaman.;Debarati Guha Sapir.;Ghassan Hage.;Ziad Majed.;Rabie Nasser.;Annie Sparrow.;Paul Spiegel.;Ahmad Tarakji.;Sarah Leah Whitson.;Nasser Yassin.
来源: Lancet. 2021年397卷10281期1245-1248页 6977. Hearing loss prevalence and years lived with disability, 1990-2019: findings from the Global Burden of Disease Study 2019.
Hearing loss affects access to spoken language, which can affect cognition and development, and can negatively affect social wellbeing. We present updated estimates from the Global Burden of Disease (GBD) study on the prevalence of hearing loss in 2019, as well as the condition's associated disability.
6978. Identification of vulnerable plaques and patients by intracoronary near-infrared spectroscopy and ultrasound (PROSPECT II): a prospective natural history study.
作者: David Erlinge.;Akiko Maehara.;Ori Ben-Yehuda.;Hans Erik Bøtker.;Michael Maeng.;Lars Kjøller-Hansen.;Thomas Engstrøm.;Mitsuaki Matsumura.;Aaron Crowley.;Ovidiu Dressler.;Gary S Mintz.;Ole Fröbert.;Jonas Persson.;Rune Wiseth.;Alf Inge Larsen.;Lisette Okkels Jensen.;Jan Erik Nordrehaug.;Øyvind Bleie.;Elmir Omerovic.;Claes Held.;Stefan K James.;Ziad A Ali.;James E Muller.;Gregg W Stone.; .
来源: Lancet. 2021年397卷10278期985-995页
Near-infrared spectroscopy (NIRS) and intravascular ultrasound are promising imaging modalities to identify non-obstructive plaques likely to cause coronary-related events. We aimed to assess whether combined NIRS and intravascular ultrasound can identify high-risk plaques and patients that are at risk for future major adverse cardiac events (MACEs).
|